# Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

> **NCT04181476** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Henry Ford Health System** · enrollment: 12 (actual)

## Conditions studied

- Sun Damaged Skin

## Interventions

- **DRUG:** Sunscreening Agents

## Key facts

- **NCT ID:** NCT04181476
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-05
- **Primary completion:** 2021-01-18
- **Final completion:** 2022-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181476, "Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04181476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*